Chemical formula: C₂₀H₂₇N₅O₃ Molecular mass: 385.468 g/mol
Tests on reproduction showed that bamifylline hydrochloride does not influence pregnancy and the embryofoetal development. However, it is advisable not to administer the drug during the first months of pregnancy, as a precautionary measure.
Under treatment with bamifylline, during pregnancy, no cases of neonatal toxicity were observed.
However, it is advisable not to take the drug during the last days of pregnancy.
Tests on reproduction showed that bamifylline hydrochloride does not influence lactation.
However, it is advisable not to take the drug during lactation.
Tests on reproduction showed that bamifylline hydrochloride does not influence fertility.
Cases of headache or gastralgia were seldom reported.
Doses higher than the therapeutical ones can induce the onset of nausea and slight distal tremors disappearing with therapy reduction.
Allergic reactions such as urticaria, itching, rash, dermatitis have been observed.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
